Chandler Robinson
CEO at Monopar Therapeutics (MNPR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 28SEC | MNPRMonopar Therapeutics | Sell Plan | 10,450117,873 held (−8%) | $87.15 | $911K | -20.5% |
| Sep 28SEC | MNPRMonopar Therapeutics | Sell Plan | 9,638108,235 held (−8%) | $87.96 | $848K | -21.2% |
| Sep 28SEC | MNPRMonopar Therapeutics | Sell Plan | 8,36899,867 held (−8%) | $88.97 | $745K | -22.1% |
| Sep 28SEC | MNPRMonopar Therapeutics | Sell Plan | 60099,267 held (−1%) | $89.79 | $54K | -22.9% |
- Sell
CEO Chandler Robinson sold $911K of MNPR at $87.15 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Chandler Robinson sold $848K of MNPR at $87.96 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Chandler Robinson sold $745K of MNPR at $88.97 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Chandler Robinson sold $54K of MNPR at $89.79 — pre-scheduled 10b5-1 plan sale.